Back to Agenda
SETTING THE SCENE: IMPORTANCE OF REGULATORY SCIENCE THROUGHOUT
Speaker(s)
The European View
Arna Hrund Arnardottir, PhD, MSc
DADA Consultancy, Iceland
Senior Consultant
FDA Perspective
Frank Weichold, MD, PhD
FDA, United States
Director, Office of Critical Path and Regulatory Science Initiatives
MEB Achievements
Christine Gispen De Wied, DrMed
Medicines Evaluation Board, Netherlands
Scientific Programmanager
Have an account?